Cross-campus research will examine why certain communities encourage behaviors like mask-wearing and social distancing more than others.
Despite the importance of detecting cognitive impairment as early as possible, only a quarter of the respondents to a USC survey reported receiving a yearly structured assessment.
They’ll be part of a national phase 3 clinical trial to test the efficacy and safety of a monoclonal antibody drug for mild to moderate COVID-19.
Giving state-level regulators more discretion in approving hydropower facilities in the United States led to faster adoption of the clean technology, a USC researcher and colleague find.
Infants born to mothers infected by the virus that causes COVID-19 could suffer from developmental difficulties and accelerated aging down the line, USC research finds.
USC researchers catalog physical and mental issues that have been exacerbated by the coronavirus pandemic.
After eight years in the Navy, Brian Phan is a well-traveled vet with a knack for photography who plans to put his USC education to use as a physician assistant.
The drugmaker says its vaccine is more than 90% effective. How did they do it? What does that mean for other vaccines in development? USC experts weigh in.
Graduates from the USC Suzanne Dworak-Peck School of Social Work have found not only jobs but personal satisfaction working with service members and their families.
